Citations

Clear

466 citation(s) found for "Josephs, Keith".

Relationship between AV‐1451‐PET and quantitative susceptibility mapping in atypical Alzheimer's disease
Singh‐Reilly, Neha, Graff‐Radford, Jonathan, Machulda, Mary M., Lowe, Val J. , Josephs, Keith A., Whitwell, Jennifer L., Satoh, Ryota , Graff‐Radford, Jonathan , Machulda, Mary M. , Josephs, Keith A. , Whitwell, Jennifer L.

Mayo Clinic

Alzheimer's & Dementia | December 25, 2025 | Volume: 21 | Issue: S2 | Pages: No page available

10.1002/alz70856_099937 Get It

Abstract Background Quantitative susceptibility mapping (QSM) can detect iron deposition or myelin loss in the brain by estimating magnetic susceptibility properties. Iron is an important component in neurofibrillary tangles and is known to co‐localize in regions with tangle burden in Alzheimer's disease (AD). Abnormal magnetic susceptibility measured on QSM has been observed in atypical AD, although it is unclear if susceptibility is regionally related to AV‐1451‐PET uptake in atypical AD. Method Forty atypical AD patients (visual variant=24, language variant=7, others=9) were recruited by the Neurodegenerative Research group from the Department of Neurology, Mayo Clinic, Rochester, MN. They underwent a 3T MRI scan with a five‐echo gradient echo sequence for calculation of QSM ( n = 80), Aβ (Pittsburgh Compound‐B) and a 18 F‐ AV‐1451 PET scan ( n = 73). All patients showed evidence of Aβ positivity on PET. To assess the relationship between QSM and AV‐1451‐PET, two approaches were used i) Voxel‐based regression analysis using VoxelStats for the whole brain, and ii) region‐of‐interest (ROI)‐based Spearman's correlation analyses using cortical and subcortical ROIs. All models were adjusted for age and sex as covariates and were corrected for multiple comparisons, specifically the VoxelStats regression maps were corrected using random field theory and the ROI‐based correlation plots were corrected using false discovery rate. Result At the voxel‐level, positive correlations between AV‐1451‐PET and QSM were only observed in the left caudate (Figure 1). At the ROI‐level, no significant associations were found, although uncorrected data showed a positive association in the occipital lobe (red circle) and a negative association between substantia nigra susceptibility and occipital AV‐1451 uptake (blue circle) (Figure 2). Since these findings did not survive corrections, they should be interpreted cautiously. Conclusion Our data provides little evidence that regional AV‐1451 PET uptake is related to susceptibility changes in patients with atypical AD, suggesting that iron deposition may not be associated with regional tau accumulation in AD.
Posterior cortical atrophy: Reorganization of the dorsal attention network and its implications on volume loss and clinical performance
Singh‐Reilly, Neha, Graff‐Radford, Jonathan, Machulda, Mary M., Schwarz, Christopher G, Knopman, D S, Petersen, R. C., Jack, Clifford R., Lowe, Val J. , Josephs, Keith A., Whitwell, Jennifer L., Graff‐Radford, Jonathan , Machulda, Mary M. , Schwarz, Christopher G. , Knopman, David S. , Petersen, Ronald, Jack, Clifford R. , Josephs, Keith A. , Whitwell, Jennifer L.

Mayo Clinic

Alzheimer's & Dementia | December 25, 2025 | Volume: 21 | Issue: S2 | Pages: No page available

10.1002/alz70856_099776 Get It

Abstract Background In addition to visuospatial and visuoperceptual deficits, most PCA patients also report deficits in visual attention, episodic memory, and working memory. The dorsal attention network is known to play a critical role in modulating these clinical functions. However, little is known about the relationship of the dorsal attention network with other core networks and relationships to volume loss and memory functions in PCA. Method Fifty‐seven PCA patients were recruited by the Neurodegenerative Research group, Mayo Clinic, and compared to 60 cognitively unimpaired (CU) individuals from the Mayo Clinic Study of Aging. The CONN functional connectivity toolbox was used to calculate within‐ and between‐network connectivity. Functional connectivity within the key regions (i.e., inter‐hemisphere connectivity) of the dorsal attention network, namely frontal eye field (FEF) and intraparietal sulcus (IPS), and the entire network was generated. Functional connectivity between the dorsal attention network and the frontoparietal, visual, and default mode networks (DMN) were also generated using CONN's network parcellation atlas. Multivariate linear regression models were fit i) to compare within‐ and between‐network connectivity between both groups and ii) to assess relationships between within‐network connectivity and both gray matter volumes and clinical test scores. Result PCA showed reduced within‐network connectivity in the dorsal attention network, specifically within the IPS and the entire network compared to CU. An increase in between‐network connectivity between the frontoparietal network and both FEF and the entire dorsal attention network was noted in PCA compared to CU (Figure 1). Lower dorsal attention within‐network connectivity was associated with a trend for lower volumes in the entire network (Figure 2) and significantly lower scores on the auditory verbal learning test‐recognition percent correct (AVLT‐RCP) and Wechsler Memory Scale (WMS) III‐digit span backward in PCA (Figure 3). Conclusion These findings suggest that within‐ and between‐network connectivity of the dorsal attention network, both within key regions and the entire network, was disrupted in PCA patients. However, this network did not show disrupted connectivity with the core PCA networks. Within‐network connectivity disruptions in the dorsal attention network are associated with aspects of memory function, and to some extent, with volume loss.
Posterior Cortical Atrophy: Altered Language Processing System Connectivity and Its Implications on Language Comprehension and Production
Singh, Neha Atulkumar , Satoh, Ryota , Hiroyuki, Watanabe , Graff-Radford, Jonathan, Machulda, Mary M. , Lowe, Val J. , Josephs, Keith A. , Whitwell, Jennifer , Singh, Neha Atulkumar , Josephs, Keith A , Lowe, Val J , Machulda, Mary M , Satoh, Ryota , Graff‐Radford, Jonathan

Mayo Clinic

Brain Sciences | December 1, 2025 | Volume: 15 | Issue: 12 | Pages: 1287

10.3390/brainsci15121287 | PMID 41440082 Get It

Background: Posterior cortical atrophy (PCA) patients typically show progressive visual decline, although language impairment can be a prominent feature. Previous studies have explored language connectivity impairment in PCA; not much is known about the exact nature of language processing disruptions in PCA. Methods: Thirty-seven PCA patients were compared with 39 cognitively unimpaired (CU) individuals. Functional connectivity was evaluated for the language processing system, which consisted of language, perceptual, motor, and cognitive networks. Linear regression was performed to compare within- and between-network connectivity across networks and within the language network in PCA compared to CU individuals. Relationships between language network connectivity, clinical performance, and gray matter volumes were also evaluated. Results: PCA showed reduced connectivity within the language and perceptual networks, along with reduced between-network connectivity compared to CU individuals. Regional connectivity breakdown within the language network was also noted. Language processing system connectivity was not associated with clinical performance on language processing tests. However, a breakdown in Broca-Wernicke, Wernicke-middle frontal gyrus, and Wernicke-frontal orbital gyrus connectivity was related to worse performance on sentence repetition. Lastly, gray matter volume was not associated with language network connectivity. Discussion: Together, these results reiterate the breakdown of language network connectivity in PCA and highlight the disruption in connectivity at the regional level within the language network. Reduced connectivity within the perceptual network and associations between reduced language network connectivity and worse performance on sentence repetition imply a breakdown within the language processing systems in PCA.
Patterns of Longitudinal Regional Brain Atrophy in Patients With Different Progressive Supranuclear Palsy Clinical Variants
Tosakulwong, Nirubol , Weigand, Stephen D. , Ali, Farwa , Stephens, Yehkyoung C. , Machulda, Mary M. , Schwarz, Christopher G. , Senjem, Matthew L. , Jack, Clifford R. , Josephs, Keith A. , Whitwell, Jennifer L. , Weigand, Stephen D , Ali, Farwa , Stephens, Yehkyoung C , Machulda, Mary M , Schwarz, Christopher G , Senjem, Matthew L , Jack, Clifford R , Josephs, Keith A , Whitwell, Jennifer , Kumar, Mahesh

Mayo Clinic

Neurology | November 25, 2025 | Volume: 105 | Issue: 12 | Pages: No page available

10.1212/wnl.0000000000214434 | PMID 41289551 Get It

Behavioral Variant Frontotemporal Dementia in the Context of Progressive Apraxia of Speech: A Clinico-Neuroimaging Case–Control Study
Hossain, Nadia , Bhaskaran, Jerusha, Duffy, Joseph R. , Clark, Heather M. , Whitwell, Jennifer L., Josephs, Keith A. , Josephs, Keith A , Clark, Heather M , Duffy, Joseph R , Hossain, Nadia , Bhaskaran, Jerusha, Machulda, Mary M. , Dickson, Dennis W. , Whitwell, Jennifer

Mayo Clinic

Brain Sciences | October 31, 2025 | Volume: 15 | Issue: 11 | Pages: 1169

10.3390/brainsci15111169 | PMID 41300176 Get It

Objective: Progressive apraxia of speech (PAOS) is a neurodegenerative syndrome characterized by impaired motor speech planning and programming, whereas behavioral variant frontotemporal dementia (bvFTD) is characterized by deviant behavioral (e.g., personality and social) features. Clinical and anatomic characteristics of bvFTD in the context of PAOS are understudied. Methods: We identified 12 participants with PAOS and features that were consistent with bvFTD at baseline or follow-up. Eleven completed a head MRI scan. We compared clinical features and anatomical patterns of atrophy in these 11 PAOS-bvFTD participants to 11 matched PAOS participants without bvFTD and 22 age- and sex-matched healthy controls. Statistical Parametric Mapping (SPM) was applied to visualize gray matter volume across both groups compared to controls and each other. Medians and 25th and 75th percentiles were assessed in patients and across groups; Fisher’s Exact Test and Mann–Whitney U tests were applied using BlueSky software, version 10.3.1-Pro. Results: As expected, PAOS-bvFTD participants performed worse on the Frontal Behavioral Inventory (median: 33/72 vs. 10/72), 20-item behavioral assessment scale (4.5/20 vs. 1.0/20), and the Neuropsychiatry inventory (4/36 vs. 1.5/36) compared to the PAOS group (p < 0.01 for all), with no differences in other demographic, neurological, or language tests. Seven of the eleven PAOS-bvFTD participants had bvFTD features develop within three years of symptom onset. The PAOS-bvFTD and PAOS groups showed volume loss in frontal lobe regions compared to controls, with PAOS-bvFTD participants having more prefrontal volume loss than PAOS participants. Conclusions: Behavioral features consistent with bvFTD can co-occur in patients with PAOS and are related to greater atrophy of the prefrontal cortex.
Imposter in the brain: aetiological, clinical and neuroimaging characteristics of Capgras syndrome
Hiroyuki, Watanabe , Whitwell, Jennifer L. , Bhaskaran, Jerusha G, Lowe, Val J. , Josephs, Keith A. , Watanabe, Hiroyuki , Bhaskaran, Jerusha G

Mayo Clinic

Brain | October 7, 2025 | Volume: 149 | Issue: 4 | Pages: 1224-1238

10.1093/brain/awaf378 | PMID 41059767 Get It

Abstract Capgras syndrome is a delusional misidentification syndrome characterized by the recurrent belief that someone, usually a family member, has been replaced by an impostor. Although described over a century ago, its aetiology, clinical features and neuroimaging characteristics remain poorly understood due to its rarity. This study aimed to clarify these aspects through the analysis of a large cohort and to explore its clinical implications and underlying mechanisms. We conducted a retrospective cohort study by reviewing medical records of patients diagnosed with Capgras syndrome at the Mayo Clinic (Rochester, MN) over a 28-year period (January 1995 to December 2022). Clinical, neuropathological and neuroimaging data were analysed. A total of 204 patients were included (median age at onset: 73 years; 44% female). Twelve patients underwent neuropathological examination, all of whom exhibited α-synuclein pathology, including one patient with a clinical diagnosis of Alzheimer’s disease (AD). Regarding clinical diagnoses, neurodegenerative diseases were the most common (69%, n = 140), with dementia with Lewy bodies (DLB) being predominant (58%, n = 118), followed by mixed aetiologies (‘two-hits’) (18%, n = 36) and AD (10%, n = 21). Psychotic disorders accounted for 9% (n = 18) of cases. No case was attributed to a single stroke, although 9% (n = 19) involved coexisting cerebrovascular disease in the context of AD or DLB. In DLB, the timing of Capgras syndrome onset varied: it occurred later than cognitive decline and core clinical features (e.g. visual hallucinations, fluctuating cognition, parkinsonism) in both DLB and mild cognitive impairment-onset prodromal DLB, but earlier in psychiatric-onset prodromal DLB. In both DLB and AD, Capgras syndrome typically targeted a single spouse, whereas in psychotic disorders, it often involved multiple, non-spousal targets. Depression or anxiety was present in 55% (n = 112). Capgras syndrome worsened in the evening or at night (87%, n = 45/52), suggesting a link to negative affective states. Among 82 patients with DLB and AD treated with cholinesterase inhibitors, 15% (n = 12) showed symptomatic improvement. Neuroimaging with MRI and 18F-fluorodeoxyglucose-PET revealed widespread bilateral cortical involvement and prominent right frontal dysfunction in DLB and AD. Capgras syndrome is associated with DLB and could serve as a potential early diagnostic clue. Recognizing its phenomenological features—the number and type of targeted individuals—can help differentiate between neurodegenerative and psychiatric aetiologies. In neurodegenerative diseases, Capgras syndrome may reflect a multifactorial, dynamic process, driven by widespread bilateral cortical dysfunction (particularly involving the right frontal lobe) and psychological factors. Thus, a combined approach involving pharmacological and non-pharmacological interventions may offer effective management strategies.
Dynamic Stability Analysis of Progressive Supranuclear Palsy Affected Gait Using Lyapunov Floquet Theory
Bhat, Sandesh G. , Ali, Farwa , Hogen, Cecilia A., Rezaei, Asghar , Josephs, Keith A. , Whitwell, Jennifer L. , Bhat, Sandesh G , Whitwell, Jennifer , Kaufman, Kenton R.

Mayo Clinic

IEEE Transactions on Neural Systems and Rehabilitation Engineering | September 25, 2025 | Volume: 33 | Issue: No issue available | Pages: 3958-3964

10.1109/tnsre.2025.3614555 | PMID 40997017 Get It

Clinicopathological and Neuroimaging Correlates of Disease Duration in Primary Progressive Apraxia of Speech
Hossain, Nadia , Bhaskaran, Jerusha, Ross, Owen A. , Whitwell, Jennifer L. , Josephs, Keith A. , Ross, Owen A , Hossain, Nadia, Clark, Heather M. , Duffy, Joseph R. , Machulda, Mary M. , Lavrova, Anna , Bhaskaran, Jerusha, Dickson, Dennis W. , Whitwell, Jennifer L.

Mayo Clinic

European Journal of Neurology | September 25, 2025 | Volume: 32 | Issue: 9 | Pages: No page available

10.1111/ene.70366 | PMID 40993958 Get It

ABSTRACTBackgroundPrimary progressive apraxia of speech is a neurodegenerative disorder characterized by early, isolated speech impairment due to impairment of motor speech planning and programming. Patients with PPAOS have varying disease durations from the estimated onset of the first symptom to death. Clinicopathological and neuroimaging features related to disease duration are unknown for PPAOS. We determine whether clinical, neuroimaging, or pathological features are associated with disease duration in primary progressive apraxia of speech (PPAOS).MethodsWe analyzed data from 41 PPAOS participants who were enrolled and longitudinally followed to death in NIH‐funded studies over 15 years. Demographic, clinical, and genetic features were abstracted. Brain volumes of cortical, subcortical, and brainstem regions were calculated. Regional tau lesion count (burden) was assessed histologically. Spearman rank correlations were performed between disease duration and variables of interest, followed by multiple regression analyses.ResultsDisease duration did not correlate with any baseline demographic, clinical, or pathologic features. Shorter disease duration correlated with a faster rate of behavioral change and of apraxia of speech severity over time, smaller baseline volumes of the superior frontal lobe and supplementary motor cortex, and higher tau burden in the locus ceruleus (ρ = −0.5, p = 0.03). Multiple regression analysis identified rate of behavioral change and volume loss in the superior frontal lobe as key clinical and neuroimaging variables, respectively.ConclusionIn patients with PPAOS, we found shorter disease duration to be related to behavioral dyscontrol and involvement of the frontal lobe, as well as a higher burden of 4‐repeat tau lesions in the locus ceruleus.
Quantitative Susceptibility Mapping and Iron Deposition in Autopsy‐Confirmed Progressive Supranuclear Palsy
Satoh, Ryota , Ali, Farwa , Whitwell, Jennifer L. , Josephs, Keith A. , Sekiya, Hiroaki , Whitwell, Jennifer , Josephs, Keith A , Satoh, Ryota , Sekiya, Hiroaki , Dickson, Dennis W.

Mayo Clinic

Movement Disorders Clinical Practice | September 17, 2025 | Volume: 13 | Issue: 3 | Pages: 785-790

10.1002/mdc3.70357 | PMID 40960890 Get It

Abstract Background Quantitative susceptibility mapping ( QSM ) is a promising neuroimaging biomarker for detecting abnormal iron deposition in progressive supranuclear palsy ( PSP ); however, the QSM profile and its accuracy in autopsy‐confirmed PSP remain unexplored. Objective The aim of the study was to elucidate and validate the QSM profiles in autopsy‐confirmed PSP. Methods Eight patients with a clinically diagnosed PSP syndrome ( PSPS ) underwent antemortem 3 T magnetic resonance imaging ( MRI) scanning and subsequent pathological diagnosis, confirming 6 PSP pathology and 2 multiple system atrophy ( MSA ) pathology cases. QSM analysis and Prussian blue staining were performed across subcortical regions. Results PSP cases showed higher susceptibility than age‐matched controls in the pallidum, subthalamic nucleus, substantia nigra, and cerebellar dentate (false discovery rate [ FDR] ‐corrected P < 0.05). PSP had higher susceptibility in the subthalamic nucleus and lower susceptibility in the putamen than the clinically atypical MSA ( P = 0.08). Subcortical susceptibilities correlated with Prussian blue–stained areas ( r = 0.63, P < 0.001). Conclusions QSM could be a reliable measure to evaluate abnormal iron accumulation patterns in PSP.
18 F‐FDG PET in detection of primary age‐related tauopathy (PART) – Is there a role? Insights from an imaging‐pathology correlation study
Pham, Nha Trang Thu, Vernon, Cynthia J. , Graff‐Radford, Jonathan, Knopman, David S. , Kantarci, Kejal , Jack, Clifford R. , Ross, Reichard R., Petersen, Ronald C. , Lowe, Val J. , Whitwell, Jennifer L. , Josephs, Keith A. , Jack, Clifford R , Kantarci, Kejal , Lavrova, Anna , Graff‐Radford, Jonathan , Boeve, Bradley F. , Knopman, David S. , Nguyen, Aivi T. , Ross, Reichard R., Dickson, Dennis W.

Mayo Clinic

Alzheimer's & Dementia | August 19, 2025 | Volume: 21 | Issue: 8 | Pages: No page available

10.1002/alz.70568 | PMID 40827317 Get It

Abstract INTRODUCTION Primary age‐related tauopathy (PART) is defined by neurofibrillary tangles (NFTs) with absent‐minimal amyloid beta (Aβ) plaques. Currently, definitive diagnosis of PART occurs with autopsy. This study investigated whether [ 18 F]fluorodeoxyglucose positron emission tomography (FDG‐PET) could detect PART‐related metabolic changes and assessed the impact of common co‐pathologies. METHODS We performed a retrospective cross‐sectional study of 88 individuals (mean age 85.6) with autopsy‐confirmed PART (Braak I to IV; Thal phases 0 to 2) who underwent ante mortem FDG‐PET. Visual ratings and standardized uptake value ratios (SUVRs) were analyzed in medial and lateral temporal lobes, inferior temporal pole, precuneus, and posterior cingulate regions. RESULTS Medial temporal hypometabolism was observed in PART, in the presence of co‐pathologies. Argyrophilic grain disease and TAR DNA‐binding protein 43 were associated with greater hypometabolism ( p < 0.01). Lewy body disease affected parietal regions. DISCUSSION FDG‐PET reveals that PART‐related hypometabolism occurs when co‐pathologies are present, but PART alone appears to have minimal effect on medial temporal lobe hypometabolism. Highlights FDG‐PET hypometabolism worsens with Braak NFT stage. FDG‐PET detects mild lateral temporal lobe hypometabolism in PART alone. PART alone has a minimal effect on medial temporal lobe hypometabolism. Medial temporal hypometabolism is worse in PART with TDP‐43 and especially AGD. The presence of LBD contributes to parietal hypometabolism on FGD‐PET in PART.